Global HIV Patients Get India Boost vs Abbott

Media Article 4 Jan 2011

India has rejected a drug patent application of a US multi-national pharma company, Abbot Laboratories, paving way for easy access to an important life-saving medication for HIV patients across the globe. Indian Express

Join us to stay updated
and help make lifesaving medicines accessible to all